People · Operator
Named in public records as an officer, director or promoter · active 2012–2026 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| FlyBy Media, Inc. | — | Other Technology | Series A | $25.1M | $166.2M | 2012 |
| Sanguine BioSciences, Inc. | — | Other Technology | Series A | $5.5M | $153.5M | 2014 |
| Sun Genomics, Inc. | — | Biotechnology | Seed | $3.6M | $131.7M | 2018 |
| Navega Therapeutics, Inc. | — | Biotechnology | Seed | $1.3M | $2.7M | 2026 |
Randy Socol at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Randy Socol on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan Perl | 1 | 10 |
| Cole Van Nice | 1 | 7 |
| Mihir Shah | 1 | 7 |
| Matthew McCooe | 1 | 5 |
| Luis Llovera | 1 | 5 |
| Joseph Del Guercio | 1 | 4 |
| Ori Inbar | 1 | 3 |
| Rudiger Hausherr | 1 | 1 |
| Brian Neman | 1 | 1 |
| Fernando Aleman | 1 | 1 |
| Ana Moreno | 1 | 1 |
| Suneer Jain | 1 | 1 |
| Frank Cooper | 1 | 1 |
| Brian Selzer | 1 | 1 |
| Oriel Bergig | 1 | 1 |
| Brad Foxhoven | 1 | 1 |
| Nate Hagbi | 1 | 1 |
| Tim Triche | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.